Brief: BD, Labcorp Collaborate To Develop Flow Cytometry-Based Companion Diagnostics For Matching Patients With Treatments

Becton Dickinson and Co

09/08/2022 13:05

Aug 9 (Reuters) - Becton Dickinson and Co  BDX.N :
    * BD, LABCORP COLLABORATE TO DEVELOP FLOW CYTOMETRY-BASED
COMPANION DIAGNOSTICS FOR MATCHING PATIENTS WITH TREATMENTS
    * BD - COLLABORATION  WITH LABCORP TO DEVELOP, MANUFACTURE,
MARKET
AND COMMERCIALIZE FLOW CYTOMETRY-BASED COMPANION DIAGNOSTICS
(CDX)
    * BD - AGREEMENT CREATES FRAMEWORK FOR COMPANIES TO
COLLABORATE ON
FLOW CYTOMETRY-BASED CDX OPPORTUNITIES WITH PHARMACEUTICAL
PARTNERS

Source text for Eikon:  ID:nPnbY9tTXa 
Further company coverage:  BDX.N